S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

CMPX Compass Therapeutics Inc

1.56

0.05 (3.31%)

28 Nov 2024 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Compass Therapeutics (NASDAQ:CMPX)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Compass Therapeutics Charts.

Compass Therapeutics (NASDAQ:CMPX)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Compass Therapeutics Charts.

Compass Therapeutics Inc News

Compass Therapeutics to Participate in Upcoming Investor Events
Thursday 14 November 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 13 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Compass Therapeutics Reports 2024 Third Quarter Financial Results and Provides Corporate Update
Wednesday 13 November 2024 (2 weeks ago) • GlobeNewswire Inc.

Compass Therapeutics Presents Novel Biomarker Data Related to CTX-471 Clinical Activity at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
Saturday 9 November 2024 (3 weeks ago) • GlobeNewswire Inc.

Compass Therapeutics Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting
Saturday 5 October 2024 (2 months ago) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Monday 9 September 2024 (3 months ago) • Edgar (US Regulatory)

Compass Therapeutics to Participate in Upcoming Investor Events
Tuesday 3 September 2024 (3 months ago) • GlobeNewswire Inc.

Form S-3 - Registration statement under Securities Act of 1933
Saturday 31 August 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 14 August 2024 (4 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Monday 12 August 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 12 August 2024 (4 months ago) • Edgar (US Regulatory)

Compass Therapeutics Reports 2024 Second Quarter Financial Results and Provides Corporate Update
Monday 12 August 2024 (4 months ago) • GlobeNewswire Inc.

More Compass Therapeutics Inc News Articles

Compam Acoro Glob Fund E...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions